Most Liquid Medical Equipment Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1CBLL CeriBell,
41.09 M
(0.04)
 3.44 
(0.15)
2OBIO Orchestra BioMed Holdings
22.17 M
(0.04)
 6.25 
(0.22)
3BBNX Beta Bionics, Common
21.7 M
(0.46)
 2.44 
(1.13)
4AVR Anteris Technologies Global
16.78 M
 0.12 
 4.16 
 0.48 
5MGRM Monogram Orthopaedics Common
16.41 M
 0.06 
 4.23 
 0.23 
6DRTSW Alpha Tau Medical
13.01 M
 0.08 
 19.19 
 1.53 
7DXCM DexCom Inc
2.37 B
 0.11 
 2.00 
 0.23 
8NSPR InspireMD
26.47 M
 0.08 
 4.40 
 0.35 
9MDAI Spectral AI
4.1 M
 0.08 
 7.76 
 0.61 
10NRXS Neuraxis,
67.17 K
(0.10)
 4.52 
(0.44)
11NVCR Novocure
948.52 M
 0.04 
 7.17 
 0.31 
12EW Edwards Lifesciences Corp
769 M
(0.01)
 1.85 
(0.02)
13NVST Envista Holdings Corp
523.1 M
(0.04)
 2.33 
(0.10)
14NVRO Nevro Corp
310.82 M
 0.10 
 5.06 
 0.50 
15OM Outset Medical
227.52 M
 0.02 
 7.13 
 0.16 
16WRBY Warby Parker
211.6 M
 0.01 
 2.81 
 0.03 
17NYXH Nyxoah
123.32 M
 0.12 
 3.07 
 0.37 
18DRTS Alpha Tau Medical
112.04 M
 0.01 
 3.83 
 0.03 
19MDXG MiMedx Group
72.5 M
(0.16)
 1.85 
(0.29)
20DRIO DarioHealth Corp
67.95 M
 0.05 
 13.34 
 0.68 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).